792 related articles for article (PubMed ID: 30528262)
21. Physiopathology and Management of Gluten-Induced Celiac Disease.
Kumar J; Kumar M; Pandey R; Chauhan NS
J Food Sci; 2017 Feb; 82(2):270-277. PubMed ID: 28140462
[TBL] [Abstract][Full Text] [Related]
22. Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease.
Tuire I; Marja-Leena L; Teea S; Katri H; Jukka P; Päivi S; Heini H; Markku M; Pekka C; Katri K
Am J Gastroenterol; 2012 Oct; 107(10):1563-9. PubMed ID: 22825364
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility of celiac disease-associated HLA testing.
Pallav K; Kabbani T; Tariq S; Vanga R; Kelly CP; Leffler DA
Dig Dis Sci; 2014 Sep; 59(9):2199-206. PubMed ID: 24705698
[TBL] [Abstract][Full Text] [Related]
24. Effect of the timing of gluten introduction on the development of celiac disease.
Silano M; Agostoni C; Guandalini S
World J Gastroenterol; 2010 Apr; 16(16):1939-42. PubMed ID: 20419830
[TBL] [Abstract][Full Text] [Related]
25. Predictors for Celiac Disease in Adult Cases of Duodenal Intraepithelial Lymphocytosis.
Aziz I; Key T; Goodwin JG; Sanders DS
J Clin Gastroenterol; 2015 Jul; 49(6):477-82. PubMed ID: 25014240
[TBL] [Abstract][Full Text] [Related]
26. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet.
Not T; Ziberna F; Vatta S; Quaglia S; Martelossi S; Villanacci V; Marzari R; Florian F; Vecchiet M; Sulic AM; Ferrara F; Bradbury A; Sblattero D; Ventura A
Gut; 2011 Nov; 60(11):1487-93. PubMed ID: 21471568
[TBL] [Abstract][Full Text] [Related]
27. Dermatitis Herpetiformis: Novel Perspectives.
Antiga E; Maglie R; Quintarelli L; Verdelli A; Bonciani D; Bonciolini V; Caproni M
Front Immunol; 2019; 10():1290. PubMed ID: 31244841
[TBL] [Abstract][Full Text] [Related]
28. T-cell and B-cell immunity in celiac disease.
du Pré MF; Sollid LM
Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):413-23. PubMed ID: 26060106
[TBL] [Abstract][Full Text] [Related]
29. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
[TBL] [Abstract][Full Text] [Related]
30. Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy.
Paolella G; Sposito S; Romanelli AM; Caputo I
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886862
[TBL] [Abstract][Full Text] [Related]
31. Genetic and flow cytometry analysis of seronegative celiac disease: a cohort study.
Ríos León R; Crespo Pérez L; Rodríguez de Santiago E; Roy Ariño G; De Andrés Martín A; García Hoz Jiménez C; Sánchez Rodríguez E; Saiz González A; León Prieto F; Albillos A
Scand J Gastroenterol; 2019 May; 54(5):563-570. PubMed ID: 31057009
[No Abstract] [Full Text] [Related]
32. [Clinical features and diagnosis of celiac disease].
Stein J
Internist (Berl); 2006 Sep; 47(9):929-37; quiz 938. PubMed ID: 16912874
[TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.
Tosco A; Maglio M; Paparo F; Rapacciuolo L; Sannino A; Miele E; Barone MV; Auricchio R; Troncone R
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):293-8. PubMed ID: 18728524
[TBL] [Abstract][Full Text] [Related]
34. Potential therapeutic options for celiac Disease: An update on Current evidence from Gluten-Free diet to cell therapy.
Noori E; Hashemi N; Rezaee D; Maleki R; Shams F; Kazemi B; Bandepour M; Rahimi F
Int Immunopharmacol; 2024 May; 133():112020. PubMed ID: 38608449
[TBL] [Abstract][Full Text] [Related]
35. Specific celiac disease antibodies in children on a gluten-free diet.
Hogen Esch CE; Wolters VM; Gerritsen SA; Putter H; von Blomberg BM; van Hoogstraten IM; Houwen RH; van der Lely N; Mearin ML
Pediatrics; 2011 Sep; 128(3):547-52. PubMed ID: 21859913
[TBL] [Abstract][Full Text] [Related]
36. Potential celiac children: 9-year follow-up on a gluten-containing diet.
Auricchio R; Tosco A; Piccolo E; Galatola M; Izzo V; Maglio M; Paparo F; Troncone R; Greco L
Am J Gastroenterol; 2014 Jun; 109(6):913-21. PubMed ID: 24777149
[TBL] [Abstract][Full Text] [Related]
37. The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000-2015).
Aziz I; Peerally MF; Barnes JH; Kandasamy V; Whiteley JC; Partridge D; Vergani P; Cross SS; Green PH; Sanders DS
Gut; 2017 Sep; 66(9):1563-1572. PubMed ID: 27605538
[TBL] [Abstract][Full Text] [Related]
38. [Celiac disease in children from the northwest of Mexico: clinical characteristics of 24 cases].
Sotelo Cruz N; Calderón de la Barca AM; Hurtado Valenzuela JG
Rev Gastroenterol Mex; 2013; 78(4):211-8. PubMed ID: 24210306
[TBL] [Abstract][Full Text] [Related]
39. Reversal of IgM deficiency following a gluten-free diet in seronegative celiac disease.
Montenegro L; Piscitelli D; Giorgio F; Covelli C; Fiore MG; Losurdo G; Iannone A; Ierardi E; Di Leo A; Principi M
World J Gastroenterol; 2014 Dec; 20(46):17686-9. PubMed ID: 25516687
[TBL] [Abstract][Full Text] [Related]
40. [Clinical manifestations of adult celiac disease].
Malamut G; Cellier C
Pathol Biol (Paris); 2013 Jun; 61(3):e47-51. PubMed ID: 21621928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
